Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Lymphoma, Mantle-Cell 9Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, B-Cell, Marginal Zone 4Waldenstrom Macroglobulinemia 3Leukemia 3Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma 2Leukemia, B-Cell 2Recurrence 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Hematologic Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 10fludarabine 7Rituximab 6Bendamustine Hydrochloride 5venetoclax 4obinutuzumab 4Lenalidomide 4ofatumumab 3ibrutinib 3fludarabine phosphate 3acalabrutinib 3Vincristine 3Immunotherapy, Adoptive 3pirtobrutinib 2Bortezomib 2Alemtuzumab 2zanubrutinib 1thymoglobulin 1tenofovir alafenamide 1ricolinostat 1pembrolizumab 1pegaspargase 1nelarabine 1idelalisib 1blinatumomab 1Whole-Body Irradiation 1Prednisolone 1Pentostatin 1Panobinostat 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, B-Cell × pirtobrutinib × Clear all
NCT07624799 2026-06-03

PACIFIC

French Innovative Leukemia Organisation

Phase 2 Not yet recruiting
82 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT06812715 2025-08-06

PIPOZA

Peter MacCallum Cancer Centre, Australia

Phase 2 Recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡